Doctors expect this will become new standard for people with mantle-cell lymphoma.
Doctors have long used rituximab to treat certain cancers, including mantle-cell lymphoma.
Long-term treatment with the drug rituximab (Rituxan) may extend the lives of some patients with a rare form of blood cancer, a new clinical trial finds.
The disease, known as mantle-cell lymphoma, is generally incurable. But various treatments can prolong people’s lives. Some patients, for instance, are able to undergo chemotherapy to wipe out the cancer cells, followed by a stem cell transplant — to restore normal blood cells.